FDA approval is the ultimate prize in the biotech industry – and one of the few major catalysts for biotech stocks. As a result, having just received FDA approval for key products, the two biotech stocks highlighted in today’s article have made their way onto Wall Street’s radar – and may be compelling biotech picks. For these two biotech stocks, CLICK HERE.